Skip to content

To study the effect of Shunthyadi Ghrut Nasya in the management of Vataj Shiroroga (Headache).

Randomised open controlled clinical study to evaluate the efficacy of Shunthyadi Ghrut Nasya in Vataj Shiroroga. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103428
Enrollment
50
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache

Interventions

None listed

Sponsors

Vd Jayashri Pandurang Bansode
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Peoples presenting signs and symptoms of Vataj Shiroroga i.e. Ghatasambheda, Shankhanistoda Headache. 2. Peoples will be selected irrespective of gender, religion, or occupation. 4. Peoples willing to participate in study. 5. Peoples fit for Nasya karma.

Exclusion criteria

Exclusion criteria: 1. Women who is under menstrual cycle. 2. Pregnant and lactating women. 3. Peoples contraindicated for Nasya karma

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Shunthyadi Ghrut nasya in Vataj Shiroroga (Shirashoola).Timepoint: 4 months

Secondary

MeasureTime frame
1.To assess the improvement in reducing symptoms of Vataj Shiroroga(Shirashoola)i.e.Ghatasambheda, Shankhanistoda and Pressing/Tightening quality pain after giving Shunthyadi Ghrut Nasya for 4 consecutive months. 2. To assess the improvement in reducing the frequency, intensity and duration of Vataj Shiroroga (Shirashoola) after giving Shunthyadi Ghrut Nasya for 4 consecutive months. 3. To evaluate improvement based on signs, symptoms and gradation of assessment criteria. 4. To achieve the outcome of study in 4 months.Timepoint: 4 months

Countries

India

Contacts

Public ContactVd Jayashri Pandurang Bansode

Yashwant ayurvedic college post graduate training and research centre, Kodoli.

abhijeetingavale@gmail.com9822919000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026